BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 5, 2011
View Archived Issues
Researchers uncover mechanism of action of epigenetic modifier UVI-5008
Read More
Nektar Therapeutics discloses novel opioid analgesic with low abuse potential
Read More
Results of phase II evaluation of evacetrapib presented
Read More
New biomarker identified in patients with myelodysplastic syndromes
Read More
Further clinical data on REGN-727 reported
Read More
Nerviano Medical Sciences presents preclinical findings on NMS-P948
Read More
AZT-2 enhances neurotransmission in preclinical models
Read More
REG2 Anticoagulation System evaluated in humans
Read More
Radikal Therapeutics presents new bifunctional PARP inhibitors
Read More
Novel mineralocorticoid receptor antagonists prepared by Pfizer
Read More
Sentinel Oncology synthesizes novel Chk1 inhibitors
Read More
Researchers at GlaxoSmithKline disclose new EZH2 inhibitors
Read More
Genentech and Gilead Sciences jointly prepare new BTK inhibitors
Read More
Sanofi recruits patients in phase I/II trial of SAR-113945
Read More
Bristol-Myers Squibb collaborates with Tibotec Pharmaceuticals on phase II HCV trial
Read More
Titan Pharmaceuticals reports FDA regulatory guidance for Probuphine NDA
Read More
Adventrx and FDA discuss development of ANX-188
Read More
Stellar Pharmaceuticals to acquire Tribute Pharmaceuticals
Read More
Bayer and Regeneron report integrated analysis of VIEW studies
Read More
Tissue Therapies enters partnerships for wound care product
Read More
GSK submits additional information to FDA for MenHibrix BLA
Read More
Cell Therapeutics provides update on MAA for Pixuvri
Read More
Kyowa Hakko Kirin launches new formulation of Nauzelin in Japan
Read More
Shire submits joint clinical trials proposal to confirm benefit of ProAmatine to FDA
Read More
Australian regulators to remove dextropropoxyphene-containing painkillers from the market
Read More
Amicus initiates phase II study of investigational chaperone with ERT in Pompe's disease
Read More